By analyzing key variants in the GLP1R, GIPR, FTO, and MC4R genes, the test reveals predispositions in peptide signaling that can support a more informed conversation with your healthcare provider about treatment candidacy and realistic expectations
Practice patterns and perspectives of the off-label use of GLP-1 agonists for cosmetic weight loss
Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME, Maggs DG
Resveratrol: Molecular mechanisms, health benefits, and potential adverse effects
Each healthcare professionals resume, medical license, and credentials are available for members to view on the platform
Resistance Exercise training in individuals with and without Cardiovascular Disease: 2023 Update: A Scientific Statement from the American Heart Association